Medication info

Rigestar Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Yuyu Pharmaceutical Co., Ltd.
Appearance
Pale orange oval film-coated tablet
Packaging
4 tablets (4 tablets/PTP × 1)
Approval status
Expired

MFDS item code 202100011 · Approved 2021.01.04

This product's status changed to Expired on 2026.01.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Take 1 tablet of this medicine orally once weekly. Older adults: No dosage adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine; therefore, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at least 2 hours apart from food or beverages at any time of day. Take this medicine with an adequate amount of plain water (170 ~ 230ml) while sitting or standing upright to help it reach the stomach and reduce the possibility of esophageal irritation. Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking it. Patients with insufficient dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., those over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. With once-weekly administration, this medicine provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Pediatric patients: The safety and efficacy of this medicine have not been established in children and growing adolescents.

Ingredients

Manufacturer
Yuyu Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medicine is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Adults: Take 1 tablet of this medicine orally once weekly. Older adults: No dosage adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine; therefore, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at least 2 hours apart from food or beverages at any time of day. Take this medicine with an adequate amount of plain water (170 ~ 230ml) while sitting or standing upright to help it reach the stomach and reduce the possibility of esophageal irritation. Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also remain upright for at least 30 minutes after taking it. Patients with insufficient dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., those over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. With once-weekly administration, this medicine provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Pediatric patients: The safety and efficacy of this medicine have not been established in children and growing adolescents.

Precautions

This medication is an oral bisphosphonate and may irritate the mucosa of the stomach and esophagus, potentially causing gastrointestinal issues such as esophagitis or esophageal ulcers. Take with a sufficient amount of water and avoid lying down for at least 30 minutes after taking. If you experience difficulty swallowing, pain behind the sternum, or heartburn, stop taking the medication immediately and consult a doctor. Patients with esophageal stricture or severe renal impairment, as well as those with lactose intolerance should not take this medication. Adequate calcium and vitamin D intake is essential while taking this medication, especially during long-term steroid therapy. Bisphosphonate drugs can rarely cause serious side effects such as osteonecrosis of the jaw, so consult a doctor if dental treatment is required. This medication should preferably not be given to pregnant or breastfeeding women, and safety in children has not been established. Overdose may lead to hypocalcemia, requiring calcium supplementation and potentially gastric lavage. During treatment, avoid taking other medications or foods containing di- or trivalent cations, as they may interfere with drug absorption. Older adults can take this medication similarly to regular adults, but they should be well informed about the dosing method and consult a doctor immediately if any abnormal symptoms occur. Lastly, this medication should be stored out of reach of children and should not be transferred to another container for safety.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • duodenal ulcer
  • nausea
Show 102 more
  • diarrhea
  • flatulence
  • gastritis
  • gastrointestinal disorders
  • rectal disorders
  • dental disorders
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension hyperactivity
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • pruritus
  • skin cancer
  • cataracts
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • influenza-like illness
  • headache
  • overdose
  • allergic reaction
  • tumor
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • polydipsia
  • peripheral edema
  • traumatic fracture
  • myopathy
  • arthritis
  • headache
  • dizziness
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • hypercholesterolemia
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • jaw necrosis
  • liver function impairment
  • jaundice
  • external auditory canal osteonecrosis
  • dyspepsia
  • loss of appetite
  • myalgia
  • abdominal pain
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial edema
  • edema
  • alopecia
  • abnormal olfaction
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • loss of appetite
  • nausea
  • vomiting
  • polyuria
  • weakness
  • drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to avoid exposure to air or moisture. It is also important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale orange oval film-coated tablet

Package unit

4 tablets (4 tablets/PTP × 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.